Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Manzano: Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). (0.11 sec) 

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

- prsjournal.com
R Manzano, GA Peyman, P Khan, PE Carvounis … - British Journal of Ophthalmology, 2007 - bjo.bmj.com
Methods: Silver nitrate sticks (75% silver nitrate, 25% potassium nitrate) were
used to perform chemical cauterisation on the corneas of 16 eyes from 16 male
Long Evans rats. For the following 7 days, the 10 eyes in the treatment ...
Cited by 72 - Related articles - BL Direct - All 6 versions

Topical bevacizumab therapy for corneal neovascularization


JJ DeStafeno, T Kim - Archives of Ophthalmology, 2007 - archopht.highwire.org
Angiogenesis has been defined as the formation of new blood vessels from
preexisting vascular structures. Corneal neovascularization (NV) occurs when the
balance between angiogenic and antiangiogenic factors shifts toward ...
Cited by 44 - Related articles - BL Direct - All 4 versions

Subconjunctival bevacizumab for corneal neovascularization

- ibuprofendrama.nl [PDF] 
M Erdurmus, Y Totan - Graefe's Archive for Clinical and Experimental …, 2007 - Springer
Abstract Objective To report the efficacy of subconjunctival bev- acizumab
injection in patients with corneal neovasculariza- tion (NV). Methods This
retrospective interventional case study in- cluded two eyes of two patients ...
Cited by 43 - Related articles - BL Direct - All 5 versions

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in …


LFM Barros, R Belfort-Jr - Anais da Academia Brasileira de Ciências, 2007 - SciELO Brasil
The purpose of this study was to evaluate the effects of the use of the
subconjunctival injection of bevacizumab (Avastin ® ) on angiogenesis in the
rat cornea. Corneas of 20 Wistar male rats were cauterized with silver ...
Cited by 24 - Related articles - Cached - BL Direct - All 5 versions

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and …

- iovs.org
F Bock, J Onderka, T Dietrich, B Bachmann, … - Investigative ophthalmology & visual science, 2007 - ARVO
METHODS. The mouse model of suture-induced corneal neovascularization was used
to assess the antihemangiogenic and antilymphangiogenic effect of bevacizumab by
systemic and topical application. Corneal flatmounts were stained with ...
Cited by 60 - Related articles - BL Direct - All 3 versions

Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of …


MD Hamid Hosseini, MD Mahmood Nejabat, MD … - Clinical & Experimental Ophthalmology - interscience.wiley.com
Methods: Chemical cauterization of the cornea was performed by touching central
cornea with a 5-mm-diameter NaOH-soaked cotton applicator for 10 s in 20 eyes of
20 White New Zealand rabbits. The rabbits were then divided randomly into ...
Cited by 23 - Related articles - BL Direct - All 3 versions

Topical bevacizumab and ocular surface neovascularization in patients with Stevens- …

- ibuprofendrama.nl [PDF] 
HS Uy, PS Chan, RE Ang - Cornea, 2008 - journals.lww.com
Methods: This was a retrospective, interventional case report. Three eyes of 2
patients were examined. Bevacizumab (25 mg/mL) eyedrops were applied 4 times
daily for a period of 3 months. Main outcome measures were improvement of ...
Cited by 27 - Related articles - BL Direct - All 4 versions

Subconjunctival bevacizumab injection for corneal neovascularization

- prsjournal.com
I Bahar, I Kaiserman, P McAllum, D Rootman, … - Cornea, 2008 - journals.lww.com
Results: No significant ocular or systemic adverse events were ob- served during
3.5 6 1.1 months of follow-up. Seven patients showed partial regression of
vessels. The extent decreased from 6.0 6 1.2 (SD) clock hours before the ...
Cited by 48 - Related articles - BL Direct - All 7 versions

A potential therapeutic strategy for inhibition of corneal neovascularization with new anti- …


H Hosseini, M Nejabat - Medical hypotheses, 2007 - Elsevier
The factors triggering corneal neovascularization involve various growth
factors. The data supporting a causal role for vascular endothelial growth
factor (VEGF) in corneal neovascularization are extensive. One possible ...
Cited by 16 - Related articles - All 22 versions

Bevacizumab (Avastin) eye drops inhibit corneal neovascularization


F Bock, Y König, F Kruse, M Baier, C … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer
Abstract Background To analyze the ability of bevacizumab (Avastin) eye drops to
inhibit corneal neovascularization. Design: interventional case series involving
five patients (age: 42±14 years). Methods Patients with aggressive corneal ...
Cited by 26 - Related articles - BL Direct - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google